Mylan looks to hit Teva where it hurts, eyeing slow-release MS treatment
April 11, 2018Research and Development, Sales and Marketing Copaxone, Mapi Pharma, Mylan, Teva, biotech, drugs, pharma, pharmaceutical
Mylan has taken several steps recently that seem intended to hit sales of its big rivals on their key products, …
May announces £75m prostate cancer boost
April 10, 2018Manufacturing and Production, Medical Communications Prostate Cancer UK, UK, biotech, drugs, pharma, pharmaceutical, prostate cancer
Prostate cancer has begun to receive more publicity in recent years in the UK, but not for the right reasons. …
Keytruda scores big as a first-line monotherapy in NSCLC patients with any level of PD-L1 expression
April 10, 2018Manufacturing and Production, Research and Development Cancer, MSD, NSCLC, keytruda, lung cancer, pharma
Closely following the news that Keytruda (pembrolizumab) had failed in the treatment of unresectable or metastatic melanoma as a combination …
Media reports over Parkinson’s drug risk hit Acadia hard
April 10, 2018Manufacturing and Production, Medical Communications Acadia Pharmaceutical, biotech, drugs, pharma, pharmaceutical
Shortly after the Institute for Safe Medication Practices released a report revealing the number of deaths of patients in those …
Antiepileptic drug use linked to increased risk of Alzheimer’s and dementia
April 10, 2018Manufacturing and Production, Research and Development Alzheimer's disease, dementia, epilepsy, pharma
A new study conducted at the University of Eastern Finland and the German Center for Neurodegenerative Diseases (DZNE) has revealed …
Immunomedics’ whirlwind in the C-suite continues
April 10, 2018Manufacturing and Production, Medical Communications AstraZeneca, Immunomedics, Seattle Genetics, biotech, drugs, pharma, pharmaceutical
Immunomedics hasn’t had the most straight forward year, its $2 billion deal with Seattle Genetics was scuppered by activist investors, …
Looking to the future of oncology
April 9, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CAR T, CAR-T, Cancer, feature, oncology, pharma
The oncology field moves so quickly that it can be hard to keep track of the latest innovations. Ben Hargreaves …
Almost 40% of UK prostate cancer cases are diagnosed late, according to report
April 9, 2018Medical Communications, Research and Development, Sales and Marketing Cancer, UK, pharma, prostate cancer
A report conducted by charity Orchid has revealed a “worrying trend” in the treatment of prostate cancer, indicating that as …
Facebook takes action against drug peddlers on Instagram
April 9, 2018Medical Communications, Sales and Marketing Facebook, biotech, drugs, fentanyl, instagram, opioid, opioid epidemic, pharma, pharmaceutical
Facebook can’t catch a break at the moment, after being widely criticised for its practices over the security of users’ …
Tecentriq third time lucky after NICE nod in lung cancer
April 9, 2018Sales and Marketing NICE, Roche, biotech, drugs, lung cancer, pharma, pharmaceutical, tecentriq
After having been knocked by twice by NICE, Roche has finally received a recommendation for Tecentriq’s second-line use in non-small …
Keytruda combo fails at Phase 3 in metastatic melanoma
April 9, 2018Research and Development, Sales and Marketing Incyte, MSD, keytruda, pharma, trial failure
Shares in biopharma firm Incyte were sent reeling by as much as 20% when the company announced that the results …
Novartis CEO makes mark with $8.7bn AveXis acquisition
April 9, 2018Sales and Marketing AveXis, Novartis, biotech, drugs, gene therapy, pharma, pharmaceutical
Vas Narasimhan’s first few moves as CEO of Novartis indicate that he is not afraid to take bold risks in …
Samsung Bioepis and Biogen secure licensing deal with Abbvie for Humira biosimilar
April 6, 2018Medical Communications, Sales and Marketing AbbVie, Biogen, Humira, Imraldi, Samsung Bioepis, biosimilar, pharma
Partners Biogen and Samsung Bioepis have secured the future of their Humira (adalimumab) biosimilar after penning a deal with Abbvie …
Top Ten most popular articles on Pharmafile.com this week
April 6, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Boehringer Ingelheim, Kite, Nordic Nanovector, Pfizer, Roche, Sanofi, biotech, cystic fibrosis, drugs, pharma, pharmaceutical
Some of the biggest news this week concerns companies that are looking to move on parts of their business, but …
Roche suffers Ocrevus knockback by NICE
April 6, 2018Medical Communications, Sales and Marketing Ocrevus, Roche, biotech, drugs, multiple sclerosis, pharma, pharmaceutical
Roche’s multiple sclerosis drug, Ocrevus (ocrelizumab), has been a big new growth driver for the company, especially in the US, …
J&J pays out $37m in damages over claims its talc contains asbestos
April 6, 2018Medical Communications, Sales and Marketing Cancer, J&J, JJ, Johnson & Johnson, mesothelioma, ovarian cancer, pharma, talc
Bad news for Johnson & Johnson as it emerges that the US pharma giant has been ordered to pay out …
Takeda move for Shire looks increasingly likely
April 6, 2018Medical Communications, Sales and Marketing Japan, Shire, Takeda, UK, biotech, drugs, pharma, pharmaceutical
Takeda’s surprise announcement, just last week, that it was weighing up a move for Shire had some analysts sceptical about …
Nordic Nanovector CEO steps down as company delays R&D timelines
April 5, 2018Medical Communications, Research and Development, Sales and Marketing Luigi Costa, Nordic Nanovector, pharma
Norwegian biopharmaceutical firm Nordic Nanovector has revealed that its Chief Executive Officer Luigi Costa is set to step down from …
Transforming cystic fibrosis treatment
April 5, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Vertex, biotech, cystic fibrosis, drugs, pharma, pharmaceutical
Fred van Goor, Principle Research Fellow at Vertex Pharmaceuticals, discusses his history of work in cystic fibrosis and how the …
Roche snaps up Inception neuroscience program
April 5, 2018Sales and Marketing Pipeline Therapeutics, Roche, biotech, drugs, pharma, pharmaceutical
Back in 2014, Roche entered into strategic collaboration with Inception Sciences to look into the regenerative medicines space for multiple …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
